Literature DB >> 19030424

[Not Available].

Jean Milot1.   

Abstract

Year:  2007        PMID： 19030424      PMCID： PMC2528784          DOI： 10.1093/pch/12.7.553

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.253


× No keyword cloud information.
  10 in total

1.  The complete elimination of retrolental fibroplasia.

Authors:  P BANISTER; J C LOCKE
Journal:  Can Med Assoc J       Date:  1957-01-15       Impact factor: 8.262

2.  Retrolental fibroplasia definitive role of oxygen administration in its etiology.

Authors:  J C LOCKE
Journal:  AMA Arch Ophthalmol       Date:  1954-01

3.  Incidence of retrolental fibroplasia in a New York nursery.

Authors:  W A SILVERMAN; F C BLODI; J C LOCKE; R L DAY; A B REESE
Journal:  AMA Arch Ophthalmol       Date:  1952-12

4.  Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach.

Authors:  K CAMPBELL
Journal:  Med J Aust       Date:  1951-07-14       Impact factor: 7.738

5.  Congenital encephalo-ophthalmic dysplasia.

Authors:  A C KRAUSE
Journal:  Arch Ophthal       Date:  1946-10

6.  Retrolental fibroplasia; etiology and prophylaxis.

Authors:  T S SZEWCZYK
Journal:  Am J Ophthalmol       Date:  1952-03       Impact factor: 5.258

7.  Retrolental fibroplasia.

Authors:  H MALLEK; P SPOHN
Journal:  Can Med Assoc J       Date:  1950-12       Impact factor: 8.262

8.  Retrolental fibroplasia in premature infants; studies on the prophylaxis of the disease; the use of alpha tocopheryl acetate.

Authors:  W C OWENS; E U OWENS
Journal:  Am J Ophthalmol       Date:  1949-12       Impact factor: 5.258

Review 9.  Retrolental fibroplasia: update.

Authors:  J T Flynn
Journal:  Trans New Orleans Acad Ophthalmol       Date:  1986

10.  Further observations on cost of preventing retrolental fibroplasia.

Authors:  D P Bolton; K W Cross
Journal:  Lancet       Date:  1974-03-16       Impact factor: 79.321
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.